Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Ziberna, K, Recalde, A, Carnicer, R, Casadei, B
Μορφή:	Conference item
Έκδοση:	Springer Berlin Heidelberg 2016

Παρόμοια τεκμήρια

Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
ανά: Mighiu, AS, κ.ά.
Έκδοση: (2021)

Role of diabetes mellitus in atrial fibrillation and potential new treatments
ανά: Ziberna, K
Έκδοση: (2020)

154 Myocardial nox2 activity regulates atrial fibrillation susceptibility
ανά: Mighiu, A, κ.ά.
Έκδοση: (2017)

Compromised redox homeostasis, altered nitroso-redox balance and therapeutic possibilities in atrial fibrillation
ανά: Simon, J, κ.ά.
Έκδοση: (2016)

BH4 supplementation as a new treatment for diabetic cardiomyopathy
ανά: Carnicer, R, κ.ά.
Έκδοση: (2019)

Identification of patients with atrial fibrillation: a big data exploratory analysis of the UK Biobank
ανά: Oster, J, κ.ά.
Έκδοση: (2020)

Dapagliflozin and Sirtuin-1 interaction and mechanism for ameliorating atrial fibrillation in a streptozotocin-induced rodent diabetic model
ανά: Wei-Chieh Lee, κ.ά.
Έκδοση: (2024-11-01)

Reduced nitric oxide bioactivity increases platelet activation in mice with streptozotocin-induced diabetes mellitus
ανά: Schafer, A, κ.ά.
Έκδοση: (2003)

Mechanisms of atrial fibrillation
ανά: Wijesurendra, RS, κ.ά.
Έκδοση: (2019)

Catheter ablation of atrial fibrillation in patients with diabetes mellitus
ανά: Allen Wang, MD, κ.ά.
Έκδοση: (2020-08-01)

Stages of development of streptozotocin-induced experimental diabetes mellitus
ανά: T. M. Boychuk, κ.ά.
Έκδοση: (2017-09-01)

Stages of development of streptozotocin-induced experimental diabetes mellitus
ανά: T. M. Boychuk, κ.ά.
Έκδοση: (2017-09-01)

BH4 increases nNOS Activity and preserves left ventricular function in diabetes
ανά: Carnicer Hijazo, R, κ.ά.
Έκδοση: (2021)

Effects of Electrical Remodeling on Atrial Fibrillation in Diabetes Mellitus
ανά: Ling-ling Qian, κ.ά.
Έκδοση: (2023-01-01)

Prognostic significance of diabetes mellitus in patients with atrial fibrillation
ανά: Andreas S. Papazoglou, κ.ά.
Έκδοση: (2021-02-01)

Phenotypes of streptozotocin-induced gestational diabetes mellitus in mice
ανά: Narumi Takahashi, κ.ά.
Έκδοση: (2024-01-01)

Phenotypes of streptozotocin-induced gestational diabetes mellitus in mice.
ανά: Narumi Takahashi, κ.ά.
Έκδοση: (2024-01-01)

Streptozotocin-induced diabetes mellitus affects lysosomal enzymes in rat liver
ανά: G.B. Peres, κ.ά.
Έκδοση: (2014-06-01)

Evaluation of the role of miR-31-dependent reduction in dystrophin and nNOS on atrial-fibrillation-induced electrical remodelling in man
ανά: Reilly, S, κ.ά.
Έκδοση: (2015)

Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus
ανά: R. Gimenes, κ.ά.
Έκδοση: (2018-01-01)

Streptozotocin model of stable diabetes mellitus
ανά: G. N. Skaletskaya, κ.ά.
Έκδοση: (2019-01-01)

The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights
ανά: Loryn J. Bohne, κ.ά.
Έκδοση: (2019-02-01)

How to risk stratify new‐onset atrial fibrillation in patients with hypertension and diabetes mellitus
ανά: Naoya Kataoka, κ.ά.
Έκδοση: (2024-02-01)

ATRIAL FIBRILLATION COMBINED WITH DIABETES MELLITUS. POSSIBILITIES OF USING RIVAROXABAN
ανά: Alexey D. Ehrlich
Έκδοση: (2018-12-01)

Mechanism of and Therapeutic Strategy for Atrial Fibrillation Associated with Diabetes Mellitus
ανά: Yubi Lin, κ.ά.
Έκδοση: (2013-01-01)

The incidence of atrial fibrillation in type 2 diabetes mellitus patients
ανά: Jandrić-Kočič Marijana
Έκδοση: (2020-01-01)

Morphology of bronchial epithelium in rodent streptozotocin-induced diabetes mellitus
ανά: Oksana Anatolyevna Pivovarova, κ.ά.
Έκδοση: (2013-12-01)

Changes in the pharmacokinetics of glibenclamide in rats with streptozotocin-induced diabetes mellitus
ανά: Yuqing Li, κ.ά.
Έκδοση: (2012-04-01)

Seek and ye shall find… subclinical atrial fibrillation in high-risk elderly patients.
ανά: Wijesurendra, R, κ.ά.
Έκδοση: (2017)

Evaluation of plasma homocysteine status in streptozotocin induced-diabetes mellitus in rabbit
ανά: K Azimzadeh, κ.ά.
Έκδοση: (2009-08-01)

Clinical Overview of Obesity and Diabetes Mellitus as Risk Factors for Atrial Fibrillation and Sudden Cardiac Death
ανά: Edwin A. Homan, κ.ά.
Έκδοση: (2019-01-01)

Diabetes Mellitus Is an Independent Risk Factor for a Stiff Left Atrial Physiology After Catheter Ablation for Atrial Fibrillation
ανά: Moon-Hyun Kim, κ.ά.
Έκδοση: (2022-03-01)

Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study
ανά: JungMin Choi, κ.ά.
Έκδοση: (2023-01-01)

Atrial fibrillation: a new facet of diabetes mellitus in the XXI century
ανά: Andrey Alexeevich Aleksandrov, κ.ά.
Έκδοση: (2011-03-01)

Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2
ανά: Alexander Kogan, κ.ά.
Έκδοση: (2023-03-01)

Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
ανά: Hisao Ogawa, κ.ά.
Έκδοση: (2022-03-01)

OSC16: Effects of streptozotocin-induced diabetes mellitus on peri-implantitis
ανά: ..
Έκδοση: (2018-01-01)

Molecular Basis of Atrial Nitroso-Redox Imbalance in Permanent Human Atrial Fibrillation
ανά: Reilly, S, κ.ά.
Έκδοση: (2009)

Atrial appendage closure is associated with increased risk for postoperative atrial fibrillation
ανά: Jeffrey H. Shuhaiber, κ.ά.
Έκδοση: (2024-11-01)

Is increased myocardial oxidative stress an early event in the natural history of atrial fibrillation?
ανά: Reilly, S, κ.ά.
Έκδοση: (2007)